RecruitingNot ApplicableNCT06888999

In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints


Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment

118 participants

Start Date

Nov 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this pilot randomised controlled trial is to investigate whether in vitro exposure by VR enhances return to work (RTW) in flight cabin crew on sick leave with mental health related complaints. The main research questions are: 1. Does VR enhances time to RTW? 2. Does VR increase self-efficacy and positive cognitions regarding RTW, and decrease job anxiety? Researchers will compare a control group receiving care as usual as provided by the occupational physician and a psychologist to an intervention group receiving care as usual plus (al least) one session with VR-glasses in which participants are virtually exposed to their workplace.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \- sick listed cabin crew with mental health related complaints that are referred by the occupational physician to a specific psychotherapist practice

Exclusion Criteria3

  • epilepsy
  • vestibular disorder
  • no signed informed consent

Interventions

OTHERIn vitro exposure to workplace by VR plus care as usual

During the VR-session, guided by the psychologist, participants are virtually exposed to their workplace using VR glasses. Based on the experience of the participants during the vitual visit to their workplace, the psychologist can adjust the therapy. In addition care as usual is provided (see description active comparator).

OTHERCare as usual: Guidance from occupational physician and psychologist focused on returning to work

Guidance by the occupational physician and a psychologist from a psychologist practice specialized in counseling cabin crew and guiding them with returning to work.


Locations(1)

KLM Health Services

Schiphol, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06888999


Related Trials